Volunteer Botanicals, conducted a gene expression study to determine how the company’s plant-based Satival powders would affect expression levels of 10 human genes closely associated with pain, wound healing and inflammation. Directed by Vanderbilt University Medical Center-trained Dr. Jacob H. Basham, the study concluded that the Satival plant-based powders demonstrated a significant increase in activation within these key genes.

“This study shows without question that no longer is there just anecdotal reports of Satival powders generating a biological effect,” stated Derek Odette, chief executive officer at Volunteer Botanicals. “We now know that the cannabinoids, botanical and vitamin formulations using Satival powder …

Full story available on Benzinga.com